Compounds > phenelzine
Page last updated: 2024-10-28

phenelzine and Neurodermatitis

phenelzine has been researched along with Neurodermatitis in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Neurodermatitis: An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, S2
Kantor, I2
Sobel, S2
Miller, R2

Trials

1 trial available for phenelzine and Neurodermatitis

ArticleYear
On the treatment of neurodermatitis with a monoamine oxidase inhibitor. The chemotherapy of psychosomatic illness through A-REM suppression.
    The Journal of nervous and mental disease, 1978, Volume: 166, Issue:2

    Topics: Adult; Clinical Trials as Topic; Dermatitis, Atopic; Diazepam; Double-Blind Method; Eczema; Female;

1978

Other Studies

1 other study available for phenelzine and Neurodermatitis

ArticleYear
A follow-up study on the chemotherapy of neurodermatitis with a monoamine oxidase inhibitor.
    The Journal of nervous and mental disease, 1978, Volume: 166, Issue:5

    Topics: Adolescent; Adult; Age Factors; Attitude to Health; Body Weight; Diet; Drug Evaluation; Female; Foll

1978